• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性血液系统恶性肿瘤的预期。

Anticipation in familial hematologic malignancies.

机构信息

Menzies Research Institute, University of Tasmania, 17 Liverpool Street, Hobart, TAS 7000, Australia.

出版信息

Blood. 2011 Jan 27;117(4):1308-10. doi: 10.1182/blood-2010-07-296475. Epub 2010 Nov 29.

DOI:10.1182/blood-2010-07-296475
PMID:21115977
Abstract

We describe a collection of 11 families with ≥ 2 generations of family members whose condition has been diagnosed as a hematologic malignancy. In 9 of these families there was a significant decrease in age at diagnosis in each subsequent generation (anticipation). The mean age at diagnosis in the first generation was 67.8 years, 57.1 years in the second, and 41.8 years in the third (P < .0002). This was confirmed in both direct parent-offspring pairs with a mean reduction of 19 years in the age at diagnosis (P = .0087) and when the analysis was repeated only including cases of mature B-cell neoplasm (P = .0007). We believe that these families provide further insight into the nature of the underlying genetic mechanism of predisposition in these families.

摘要

我们描述了 11 个家族,这些家族至少有两代以上的家庭成员被诊断患有血液系统恶性肿瘤。在其中 9 个家族中,每个后续世代的诊断年龄都显著降低( anticipation )。第一代的平均诊断年龄为 67.8 岁,第二代为 57.1 岁,第三代为 41.8 岁(P<.0002)。这在直接的父母-子女对中得到了证实,诊断年龄平均降低了 19 岁(P=.0087),当仅包括成熟 B 细胞肿瘤的病例进行分析时,结果也是如此(P=.0007)。我们认为这些家族进一步揭示了这些家族中易感性潜在遗传机制的本质。

相似文献

1
Anticipation in familial hematologic malignancies.家族性血液系统恶性肿瘤的预期。
Blood. 2011 Jan 27;117(4):1308-10. doi: 10.1182/blood-2010-07-296475. Epub 2010 Nov 29.
2
Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.个体及家族中肾细胞癌和血液系统恶性肿瘤(主要为淋巴样肿瘤)的发生情况。
Fam Cancer. 2016 Oct;15(4):677-87. doi: 10.1007/s10689-016-9911-7.
3
[Anticipation in familial malignant hematologic diseases (epidemiologic observations)].
Orv Hetil. 2002 Aug 11;143(32):1887-91.
4
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).在遗传性血液系统恶性肿瘤诊所(HHMC)对疑似血液系统恶性肿瘤易感性的患者及其家属进行评估。
Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):417-428.e2. doi: 10.1016/j.clml.2016.04.001. Epub 2016 Apr 27.
5
Anticipation in familial plasma cell dyscrasias.
Br J Haematol. 1998 Dec;103(3):696-703. doi: 10.1046/j.1365-2141.1998.01061.x.
6
The Familial Tasmanian Haematological Malignancies Study (FaTHMS): its origins, its history and the phenomenon of anticipation.
Transfus Apher Sci. 2013 Oct;49(2):113-5. doi: 10.1016/j.transci.2013.07.011. Epub 2013 Aug 19.
7
Genetic anticipation in a special form of hypertrophic cardiomyopathy with sudden cardiac death in a family with 74 members across 5 generations.在一个五代共74名成员的家族中,一种特殊形式的肥厚型心肌病伴心源性猝死存在遗传早现现象。
Medicine (Baltimore). 2017 Mar;96(11):e6249. doi: 10.1097/MD.0000000000006249.
8
Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree.家族谱系中有霍奇金淋巴瘤和非霍奇金淋巴瘤的家庭中的遗传早现现象。
Leuk Lymphoma. 2006 Oct;47(10):2115-27. doi: 10.1080/10428190600724928.
9
Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma.家族性非霍奇金淋巴瘤中预期性发病年龄的证据。
Br J Haematol. 2000 Jan;108(1):72-9. doi: 10.1046/j.1365-2141.2000.01815.x.
10
Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.意大利南部患者群体中的家族性B细胞慢性淋巴细胞白血病
Int J Hematol. 2004 May;79(4):354-7. doi: 10.1532/ijh97.e0304.

引用本文的文献

1
Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago Experience.生殖系易患造血系统恶性肿瘤的临床评估与诊断:芝加哥大学的经验
Front Pediatr. 2017 Dec 6;5:252. doi: 10.3389/fped.2017.00252. eCollection 2017.
2
Genetic predisposition to hematologic malignancies: management and surveillance.血液系统恶性肿瘤的遗传易感性:管理与监测
Blood. 2017 Jul 27;130(4):424-432. doi: 10.1182/blood-2017-02-735290. Epub 2017 Jun 9.
3
A retrospective examination of mean relative telomere length in the Tasmanian Familial Hematological Malignancies Study.
塔斯马尼亚家族性血液系统恶性肿瘤研究中平均相对端粒长度的回顾性分析。
Oncol Rep. 2015 Jan;33(1):25-32. doi: 10.3892/or.2014.3568. Epub 2014 Oct 24.